BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human gastric juice protein. It is one of the most extensively referenced peptides in published preclinical literature. Manufactured to ≥99% purity with independent third-party verification.

BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a sequence found in human gastric juice. It is one of the most extensively referenced peptides in published preclinical literature. Supplied as a high-purity lyophilized research peptide.

BPC-157 was first isolated and characterized by researchers led by Predrag Sikiric at the University of Zagreb, Croatia, beginning in the early 1990s. The peptide sequence was derived from a stable gastric pentadecapeptide found in human gastric juice. Over 100 published preclinical studies have referenced this compound.

This peptide carries the True Research Certified designation, awarded exclusively to compounds that achieve verified ≥99% purity through independent third-party HPLC and mass spectrometry analysis. True Research Certified products undergo batch-level endotoxin screening via the LAL (Limulus Amebocyte Lysate) method and are accompanied by a comprehensive Certificate of Analysis (COA) documenting purity, identity, and endotoxin results. This certification reflects our commitment to supplying only the highest-grade research materials to the scientific community.